Laurus Labs Future Growth
Future criteria checks 4/6
Laurus Labs is forecast to grow earnings and revenue by 50.8% and 13.9% per annum respectively. EPS is expected to grow by 41% per annum. Return on equity is forecast to be 14% in 3 years.
Key information
50.8%
Earnings growth rate
41.0%
EPS growth rate
Pharmaceuticals earnings growth | 17.5% |
Revenue growth rate | 13.9% |
Future return on equity | 14.0% |
Analyst coverage | Good |
Last updated | 29 Jul 2024 |
Recent future growth updates
Recent updates
Here's Why It's Unlikely That Laurus Labs Limited's (NSE:LAURUSLABS) CEO Will See A Pay Rise This Year
Jul 05Laurus Labs Limited's (NSE:LAURUSLABS) Price In Tune With Revenues
Jul 03Laurus Labs' (NSE:LAURUSLABS) Dividend Will Be ₹0.40
Apr 28Laurus Labs Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Jan 27Is Laurus Labs (NSE:LAURUSLABS) A Risky Investment?
Dec 01Laurus Labs (NSE:LAURUSLABS) Is Paying Out Less In Dividends Than Last Year
Oct 22These 4 Measures Indicate That Laurus Labs (NSE:LAURUSLABS) Is Using Debt Reasonably Well
Jul 06Laurus Labs (NSE:LAURUSLABS) Is Paying Out A Dividend Of ₹1.20
Apr 30Is Laurus Labs (NSE:LAURUSLABS) A Risky Investment?
Dec 18Is Laurus Labs Limited (NSE:LAURUSLABS) Expensive For A Reason? A Look At Its Intrinsic Value
Sep 27Is Laurus Labs (NSE:LAURUSLABS) Using Too Much Debt?
Sep 09Laurus Labs (NSE:LAURUSLABS) Has A Somewhat Strained Balance Sheet
Jun 11Laurus Labs (NSE:LAURUSLABS) Is Paying Out A Larger Dividend Than Last Year
May 02Laurus Labs (NSE:LAURUSLABS) Seems To Use Debt Quite Sensibly
Feb 26With EPS Growth And More, Laurus Labs (NSE:LAURUSLABS) Is Interesting
Feb 11Does Laurus Labs (NSE:LAURUSLABS) Have A Healthy Balance Sheet?
Nov 26Laurus Labs (NSE:LAURUSLABS) Is Due To Pay A Dividend Of ₹0.80
Nov 13I Ran A Stock Scan For Earnings Growth And Laurus Labs (NSE:LAURUSLABS) Passed With Ease
Nov 12Laurus Labs (NSE:LAURUSLABS) Has Affirmed Its Dividend Of ₹0.80
Oct 30A Look At The Intrinsic Value Of Laurus Labs Limited (NSE:LAURUSLABS)
Oct 05Should You Be Adding Laurus Labs (NSE:LAURUSLABS) To Your Watchlist Today?
Aug 10Laurus Labs (NSE:LAURUSLABS) Seems To Use Debt Quite Sensibly
Jul 23Is Laurus Labs Limited (NSE:LAURUSLABS) Worth ₹547 Based On Its Intrinsic Value?
Jun 06We Think That There Are Issues Underlying Laurus Labs' (NSE:LAURUSLABS) Earnings
May 06Should You Be Adding Laurus Labs (NSE:LAURUSLABS) To Your Watchlist Today?
May 05We Think Laurus Labs (NSE:LAURUSLABS) Can Stay On Top Of Its Debt
Mar 16Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 73,610 | 8,181 | 4,471 | N/A | 8 |
3/31/2026 | 66,905 | 6,879 | 2,074 | N/A | 14 |
3/31/2025 | 57,523 | 3,934 | 3,691 | N/A | 14 |
6/30/2024 | 50,540 | 1,482 | N/A | N/A | N/A |
3/31/2024 | 50,408 | 1,606 | -126 | 6,657 | N/A |
12/31/2023 | 49,821 | 1,879 | N/A | N/A | N/A |
9/30/2023 | 53,320 | 3,678 | 2,870 | 12,248 | N/A |
6/30/2023 | 56,834 | 5,637 | N/A | N/A | N/A |
3/31/2023 | 60,406 | 7,901 | 37 | 9,939 | N/A |
12/31/2022 | 60,845 | 9,176 | N/A | N/A | N/A |
9/30/2022 | 55,684 | 8,683 | 13 | 8,393 | N/A |
6/30/2022 | 51,960 | 8,374 | N/A | N/A | N/A |
3/31/2022 | 49,356 | 8,275 | 343 | 9,111 | N/A |
12/31/2021 | 49,227 | 8,937 | N/A | N/A | N/A |
9/30/2021 | 51,823 | 10,128 | -1,705 | 7,112 | N/A |
6/30/2021 | 51,177 | 10,532 | N/A | N/A | N/A |
3/31/2021 | 48,135 | 9,836 | 442 | 7,330 | N/A |
12/31/2020 | 42,407 | 7,971 | N/A | N/A | N/A |
9/30/2020 | 36,819 | 5,977 | 1,548 | 5,427 | N/A |
6/30/2020 | 32,555 | 4,120 | N/A | N/A | N/A |
3/31/2020 | 28,317 | 2,553 | 1,252 | 3,474 | N/A |
12/31/2019 | 26,277 | 1,883 | N/A | N/A | N/A |
9/30/2019 | 24,276 | 1,326 | 1,613 | 3,538 | N/A |
6/30/2019 | 23,035 | 923 | N/A | N/A | N/A |
3/31/2019 | 22,919 | 938 | 434 | 2,977 | N/A |
12/31/2018 | 22,170 | 957 | N/A | N/A | N/A |
9/30/2018 | 21,665 | 1,127 | N/A | N/A | N/A |
6/30/2018 | 21,168 | 1,453 | N/A | N/A | N/A |
3/31/2018 | 20,562 | 1,676 | N/A | 3,425 | N/A |
12/31/2017 | 19,687 | 1,917 | N/A | N/A | N/A |
9/30/2017 | 19,954 | 2,019 | N/A | N/A | N/A |
6/30/2017 | 19,733 | 2,014 | N/A | N/A | N/A |
3/31/2017 | 19,046 | 1,881 | N/A | 3,320 | N/A |
3/31/2016 | 17,776 | 1,337 | N/A | 1,820 | N/A |
3/31/2015 | 13,266 | 684 | N/A | -647 | N/A |
3/31/2014 | 11,597 | 972 | N/A | 1,212 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LAURUSLABS's forecast earnings growth (50.8% per year) is above the savings rate (6.7%).
Earnings vs Market: LAURUSLABS's earnings (50.8% per year) are forecast to grow faster than the Indian market (16.7% per year).
High Growth Earnings: LAURUSLABS's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: LAURUSLABS's revenue (13.9% per year) is forecast to grow faster than the Indian market (9.8% per year).
High Growth Revenue: LAURUSLABS's revenue (13.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: LAURUSLABS's Return on Equity is forecast to be low in 3 years time (14%).